Clinical Trial Update: Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a topical engineered Lactobacillus reuteri with a zinc sulfate-tannic acid MPN coating for acne; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• Engineered Lactobacillus reuteri topical formulation with zinc sulfate-tannic acid MPN coating (Lactobacillus reuteri topical live biotherapeutic with zinc sulfate-tannic acid MPN coating)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Acne | Phase 2 | Status: RECRUITING